Literature DB >> 16448632

Is it the primetime for endoglin (CD105) in the clinical setting?

Michele Maio, Maresa Altomonte, Ester Fonsatti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16448632     DOI： 10.1016/j.cardiores.2006.01.007

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  2 in total

Review 1.  Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.

Authors:  José M Ferreras; Lucía Citores; Rosario Iglesias; Pilar Jiménez; Tomás Girbés
Journal:  Toxins (Basel)       Date:  2011-04-29       Impact factor: 4.546

2.  Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature review.

Authors:  Simona Gurzu; Diana Ciortea; Teodora Munteanu; Iringo Kezdi-Zaharia; Ioan Jung
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.